Subsidiaries of Ortho Clinical Diagnostics increased the revolving credit facility under a 2014 credit agreement by $150 million to $500 million. According to an 8K, Barclays Bank is serving as administrative agent and collateral agent for the facility.
Ortho-Clinical Diagnostic refinanced its credit agreement. The amended agreement consists of a $2.325 billion term B loan and a $350 revolving credit facility.
Reuters reported that Ortho-Clinical Diagnostics, a unit of Johnson & Johnson, will launch a $2.525 billion senior secured credit facility to finance its acquisition by Carylyle Group.